Content is free to use but usage restrictions apply. Please visit our FAQ for conditions of use. If you click download/embed, you acknowledge that you have read and will respect the terms of use.
Sudden US backing for a global waiver on patent protections for Covid-19 vaccines offers hope to poor nations struggling for doses -- but big pharma thinks the notion misguided
